Drugs / BLI801
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 24 trials | ||||||
| Phase 2 | NCT02820714 | Feb 2016 → Jan 2017 | constipation disorder | Braintree Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT01687985 | Aug 2012 → Mar 2013 | constipation disorder | Braintree Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT01301781 | Jan → May 2011 | constipation disorder | Braintree Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT00583154 | Oct 2007 → Jan 2008 | constipation disorder | Braintree Laboratories | Completed | No outcome recorded |
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT02822508 | Jun 2016 → Apr 2017 | constipation disorder | Braintree Laboratories | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BLI801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02822508 ↗ |
| Route | Oral | “oral solution” NCT01301781 ↗ |